These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 17553037

  • 1. The challenge of follow-up in narrowband ultraviolet B phototherapy.
    Diffey BL, Farr PM.
    Br J Dermatol; 2007 Aug; 157(2):344-9. PubMed ID: 17553037
    [Abstract] [Full Text] [Related]

  • 2. A randomized comparison of selective broadband UVB and narrowband UVB in the treatment of psoriasis.
    Kirke SM, Lowder S, Lloyd JJ, Diffey BL, Matthews JN, Farr PM.
    J Invest Dermatol; 2007 Jul; 127(7):1641-6. PubMed ID: 17380117
    [Abstract] [Full Text] [Related]

  • 3. Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy.
    Hearn RM, Kerr AC, Rahim KF, Ferguson J, Dawe RS.
    Br J Dermatol; 2008 Sep; 159(4):931-5. PubMed ID: 18834483
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Narrow-band UVB therapy in psoriasis vulgaris: good practice guideline and recommendations of the French Society of Photodermatology].
    Beani JC, Jeanmougin M.
    Ann Dermatol Venereol; 2010 Jan; 137(1):21-31. PubMed ID: 20110064
    [Abstract] [Full Text] [Related]

  • 6. Photocarcinogenic Risk Associated With Narrowband UV-B Phototherapy: An Epidemiologic Study in a Tertiary Care Hospital.
    Ortiz-Salvador JM, Ferrer DS, Saneleuterio-Temporal M, Victoria Martínez AM, Ferriols AP, Vilata Corell JJ, Alegre de Miquel V.
    Actas Dermosifiliogr (Engl Ed); 2018 May; 109(4):340-345. PubMed ID: 29463381
    [Abstract] [Full Text] [Related]

  • 7. The photocarcinogenic risk of narrowband UVB (TL-01) phototherapy: early follow-up data.
    Man I, Crombie IK, Dawe RS, Ibbotson SH, Ferguson J.
    Br J Dermatol; 2005 Apr; 152(4):755-7. PubMed ID: 15840109
    [Abstract] [Full Text] [Related]

  • 8. Cutaneous carcinogenic risk evaluation in 375 patients treated with narrowband-UVB phototherapy: A 15-year experience from our Institute.
    Raone B, Patrizi A, Gurioli C, Gazzola A, Ravaioli GM.
    Photodermatol Photoimmunol Photomed; 2018 Sep; 34(5):302-306. PubMed ID: 29533483
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Risk of skin cancer in psoriasis patients receiving long-term narrowband ultraviolet phototherapy: Results from a Taiwanese population-based cohort study.
    Lin TL, Wu CY, Chang YT, Juan CK, Chen CC, Yu SH, Chen YJ.
    Photodermatol Photoimmunol Photomed; 2019 May; 35(3):164-171. PubMed ID: 30536640
    [Abstract] [Full Text] [Related]

  • 11. The risk of skin cancer in psoriasis patients treated with UVB therapy.
    Osmancevic A, Gillstedt M, Wennberg AM, Larkö O.
    Acta Derm Venereol; 2014 Jul; 94(4):425-30. PubMed ID: 24322826
    [Abstract] [Full Text] [Related]

  • 12. A new development in UVB phototherapy of psoriasis.
    van Weelden H, De La Faille HB, Young E, van der Leun JC.
    Br J Dermatol; 1988 Jul; 119(1):11-9. PubMed ID: 3408653
    [Abstract] [Full Text] [Related]

  • 13. Melanoma and non-melanoma skin cancer in psoriatic patients treated with high-dose phototherapy.
    Maiorino A, De Simone C, Perino F, Caldarola G, Peris K.
    J Dermatolog Treat; 2016 Oct; 27(5):443-7. PubMed ID: 26822468
    [Abstract] [Full Text] [Related]

  • 14. Paediatric psoriasis--narrowband UVB treatment.
    Zamberk P, Velázquez D, Campos M, Hernanz JM, Lázaro P.
    J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):415-9. PubMed ID: 19754659
    [Abstract] [Full Text] [Related]

  • 15. Validation of a semiautomated method of minimal erythema dose testing for narrowband ultraviolet B phototherapy.
    Otman SG, Edwards C, Gambles B, Anstey AV.
    Br J Dermatol; 2006 Aug; 155(2):416-21. PubMed ID: 16882183
    [Abstract] [Full Text] [Related]

  • 16. Quality of life in psoriasis improves after standardized administration of narrowband UVB phototherapy.
    Lim C, Brown P.
    Australas J Dermatol; 2006 Feb; 47(1):37-40. PubMed ID: 16405481
    [Abstract] [Full Text] [Related]

  • 17. Serum 5-S-cysteinyldopa levels in patients with psoriasis undergoing narrowband ultraviolet B phototherapy.
    Kikuchi K, Wakamatsu K, Tada Y, Komine M, Ito S, Tamaki K.
    Clin Exp Dermatol; 2008 Nov; 33(6):750-3. PubMed ID: 18954414
    [Abstract] [Full Text] [Related]

  • 18. PUVA, UVB, psoriasis, and nonmelanoma skin cancer.
    Studniberg HM, Weller P.
    J Am Acad Dermatol; 1993 Dec; 29(6):1013-22. PubMed ID: 8245237
    [Abstract] [Full Text] [Related]

  • 19. Self-administration of hospital-based narrowband ultraviolet B (TL-01) phototherapy: a feasibility study in an outpatient setting.
    Yule S, Sanyal S, Ibbotson S, Moseley H, Dawe RS.
    Br J Dermatol; 2013 Aug; 169(2):464-8. PubMed ID: 23488569
    [Abstract] [Full Text] [Related]

  • 20. Narrowband ultraviolet B (UVB) phototherapy in children.
    Jury CS, McHenry P, Burden AD, Lever R, Bilsland D.
    Clin Exp Dermatol; 2006 Mar; 31(2):196-9. PubMed ID: 16487089
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.